4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-19-007033
SVP, Chief Medical Officer gave up 706 shares (to pay taxes)
- SVP, Chief Medical Officer acquired 2,043 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Chondros Dimitrios · SVP, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-01 | Exercise or conversion : show line 1 in the form | +2,043 | 40,618 | D | ||
| 2019-06-01 | Shares withheld for taxes : show line 2 in the form | −706 | $14.75 | $10,414 | 39,912 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −2,043 | $0.00 | 2,043 | 4,084 | D |
Loading xslF345X03/edgar.xml…